MPM BIOVENTURES 2018 L.P. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 4:06 pm Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 3,451,303 4.300% |
-1,519,596 (-30.57%) |
Filing |
| 2023-02-09 4:04 pm Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 4,970,899 9.500% |
19,596 (+0.40%) |
Filing |
| 2021-02-12 4:24 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 4,951,303 10.900% |
4,951,303 (New Position) |
Filing |